Insider · CIK 0001659085

Sender Gary

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001659085

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-14	IBIOiBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+38K sh	—	—	38,000
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−51.9K sh	—	—	0
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+51.9K sh	—	—	51,890
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44.5K sh	—	—	0
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+44.5K sh	—	—	44,477
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+44.5K sh	—	—	44,477
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44.5K sh	—	—	0
2026-07-30	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+44.5K sh	—	—	44,477
2026-06-22	SDGRSchrodinger, Inc.A Award	Director	AAward	+8,141 sh	—	—	25,388
2026-06-22	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,313
2026-05-14	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+21.9K sh	—	—	21,872
2025-11-20	IBIOiBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2025-06-18	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,341 sh	—	—	9,341
2025-06-18	SDGRSchrodinger, Inc.A Award	Director	AAward	+5,997 sh	—	—	17,247
2025-05-15	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+14.5K sh	—	—	14,522
2025-01-10	IBIOiBio, Inc.P Purchase	Director	PPurchase	+9,191 sh	$2.72	+$25K	9,191
2024-11-21	IBIOiBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,900
2024-06-18	SDGRSchrodinger, Inc.A Award	Director	AAward	+5,000 sh	—	—	11,250
2024-06-18	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,550 sh	—	—	8,550
2024-05-29	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+11.7K sh	—	—	11,657
2023-06-15	SDGRSchrodinger, Inc.A Award	Director	AAward	+6,250 sh	—	—	6,250
2023-06-15	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-05-25	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+9,613 sh	—	—	48,255
2022-06-15	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.9K sh	—	—	14,907
2022-05-20	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+8,726 sh	—	—	8,726
2021-12-09	IBIOiBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+109K sh	—	—	109,000
2021-06-17	SDGRSchrodinger, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,736 sh	—	—	8,736
2021-05-20	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+13.3K sh	—	—	13,333
2021-03-08	SDGRSchrodinger, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	24,246
2021-03-08	SDGRSchrodinger, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.9K sh	—	—	19
2021-03-08	SDGRSchrodinger, Inc.S Sale	Director	SSale	−28.8K sh	$66.55	−$1.91M	0
2021-03-08	SDGRSchrodinger, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.9K sh	$17.00	+$219K	28,775
2021-03-08	SDGRSchrodinger, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	$5.31	+$84.3K	15,885
2021-02-28	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−31 sh	$2.39	−$74.09	20,472
2021-01-31	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−37 sh	$2.62	−$96.94	20,503
2020-12-31	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−32 sh	$2.42	−$77.44	20,540
2020-11-30	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−312 sh	$0.43	−$133.224	205,728
2020-10-31	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−312 sh	$0.50	−$154.596	206,040
2020-10-14	IBIOiBio, Inc. · Stock OptionA Award	Director	AAward	+100K sh	—	—	100,000
2020-09-30	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−312 sh	$0.53	−$166.296	206,352
2020-08-31	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−312 sh	$0.62	−$193.253	206,664
2020-08-20	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−3,204 sh	$0.65	−$2,074.91	206,976
2020-08-19	Nabriva Therapeutics plcM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.3K sh	—	—	210,180
2020-08-19	Nabriva Therapeutics plcRestricted Share UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.3K sh	—	—	0
2020-08-18	HRMYHarmony Biosciences Holdings, Inc. · Stock OptionA Award	Director	AAward	+16.6K sh	—	—	16,583
2020-07-31	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−312 sh	$0.76	−$237.12	198,930
2020-06-30	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−312 sh	$0.67	−$210.475	199,242
2020-05-31	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−312 sh	$1.14	−$355.68	199,554
2020-04-30	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−301 sh	$0.55	−$165.038	193,679
2020-03-31	Nabriva Therapeutics plcF Tax Payment	Chief Financial Officer	FTax Payment	−301 sh	$0.57	−$173.075	193,980

Recent filings

Accepted (ET)
Oct 15 18:304
Sender Gary0001104659-26-116317
SEC(opens sec.gov)
Aug 34
Sender Gary0001193125-26-330504
SEC(opens sec.gov)
Jun 234
Sender Gary0001659085-26-000003
SEC(opens sec.gov)
May 184
Sender Gary0001659085-26-000002
SEC(opens sec.gov)
Nov 244
Sender Gary0001104659-25-115410
SEC(opens sec.gov)
Jun 204
Sender Gary0001490978-25-000091
SEC(opens sec.gov)
May 164
Sender Gary0001415889-25-013397
SEC(opens sec.gov)
Jan 134
Sender Gary0001104659-25-003058
SEC(opens sec.gov)
Nov 254
Sender Gary0001104659-24-122595
SEC(opens sec.gov)
Jun 204
Sender Gary0001490978-24-000057
SEC(opens sec.gov)
May 314
Sender Gary0001415889-24-014970
SEC(opens sec.gov)

Companies

Address

C/O IBIO, INC. 11750 SORRENTO VALLEY ROAD, SUITE 200

SAN DIEGO, CA, 92121